8,145 Shares in Xylem Inc. $XYL Acquired by Inceptionr LLC

Inceptionr LLC acquired a new stake in shares of Xylem Inc. (NYSE:XYLFree Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 8,145 shares of the industrial products company’s stock, valued at approximately $973,000.

Other large investors have also added to or reduced their stakes in the company. J. Stern & Co. LLP grew its stake in shares of Xylem by 12,326.6% in the fourth quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock worth $6,189,132,000 after acquiring an additional 45,082,435 shares during the last quarter. Norges Bank purchased a new position in shares of Xylem in the 4th quarter worth about $361,012,000. SEB Asset Management AB bought a new position in Xylem in the 1st quarter worth about $66,700,000. Balyasny Asset Management L.P. boosted its stake in Xylem by 346.2% in the 3rd quarter. Balyasny Asset Management L.P. now owns 712,950 shares of the industrial products company’s stock worth $105,160,000 after purchasing an additional 553,152 shares in the last quarter. Finally, Adage Capital Partners GP L.L.C. purchased a new stake in Xylem during the 2nd quarter valued at about $64,407,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Wall Street Analysts Forecast Growth

XYL has been the subject of a number of analyst reports. Oppenheimer reduced their price objective on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a research note on Wednesday, April 29th. Royal Bank Of Canada upped their target price on shares of Xylem from $157.00 to $159.00 and gave the stock an “outperform” rating in a research note on Thursday, July 16th. JPMorgan Chase & Co. cut their price target on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, April 16th. CLSA raised shares of Xylem to a “hold” rating in a research report on Thursday, June 25th. Finally, Barclays decreased their price objective on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a report on Wednesday, April 29th. Eight analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $153.15.

View Our Latest Analysis on Xylem

Insider Activity at Xylem

In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of the firm’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the sale, the chief accounting officer owned 3,605 shares in the company, valued at approximately $423,443.30. This trade represents a 54.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Jerome A. Peribere bought 1,210 shares of the business’s stock in a transaction on Monday, May 4th. The stock was bought at an average cost of $116.61 per share, with a total value of $141,098.10. Following the transaction, the director owned 27,209 shares in the company, valued at $3,172,841.49. This trade represents a 4.65% increase in their position. The disclosure for this purchase is available in the SEC filing. 0.32% of the stock is owned by insiders.

Xylem Price Performance

NYSE XYL opened at $119.66 on Friday. Xylem Inc. has a one year low of $105.29 and a one year high of $154.27. The stock has a 50-day moving average of $114.04 and a 200 day moving average of $122.82. The company has a market capitalization of $28.44 billion, a price-to-earnings ratio of 29.77, a PEG ratio of 1.66 and a beta of 1.03. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46.

Xylem (NYSE:XYLGet Free Report) last issued its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.09 by $0.03. The business had revenue of $2.12 billion during the quarter, compared to analyst estimates of $2.11 billion. Xylem had a return on equity of 11.26% and a net margin of 10.79%.Xylem’s revenue was up 2.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.03 EPS. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, sell-side analysts forecast that Xylem Inc. will post 5.52 EPS for the current year.

Xylem Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were issued a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 1.4%. The ex-dividend date of this dividend was Thursday, May 28th. Xylem’s payout ratio is presently 42.79%.

Xylem Profile

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Featured Articles

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.